Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic - human insulin - 25 years ago. Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy. In this article, we decided to evaluate Five Prime Therapeutics (NASDAQ:FPRX), a small-cap biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases.
Five Prime was incorporated in Delaware in 2001 and is headquartered in South San Francisco, California. Five Prime has developed the industry's most comprehensive protein library consisting of more than 5,600...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|